Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 7.96
+0.29 (3.78%)
Jul 9, 2026, 4:08 PM HKT
HKG:2591 Market Cap
HKG:2591 has a market cap or net worth of 3.64 billion as of July 9, 2026.
Market Cap
3.64B
Enterprise Value
2.48B
Revenue
146.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.96
Market Cap Chart
Since August 15, 2025, HKG:2591's market cap has decreased from 26.15B to 3.64B, a decrease of -86.10%. That is a compound annual growth rate of -88.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.64B | -74.02% |
| Dec 31, 2025 | 14.00B | -46.48% |
| Aug 15, 2025 | 26.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 4.60B |
| Ocumension Therapeutics | 4.02B |
| Jacobio Pharmaceuticals Group | 3.87B |
| Qyuns Therapeutics | 3.74B |
| Mirxes Holding Company | 3.66B |
| Shandong Boan Biotechnology | 3.22B |
| Medtide | 3.14B |
| Jiangsu Recbio Technology | 3.08B |